Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer’s disease models: a systematic review and meta-analysis of preclinical studies

Alzheimer’s disease (AD) is a degenerative disease of the nervous system. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a drug used to treat type 2 diabetes, have been shown to have neuroprotective effects. This systematic review and meta-analysis evaluated the effects and potential mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Fanjing, Wu, Tianyu, Dai, Jingyi, Zhai, Zhenwei, Cai, Jie, Zhu, Zhishan, Xu, Ying, Sun, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525376/
https://www.ncbi.nlm.nih.gov/pubmed/37771725
http://dx.doi.org/10.3389/fphar.2023.1205207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525376/
https://www.ncbi.nlm.nih.gov/pubmed/37771725
http://dx.doi.org/10.3389/fphar.2023.1205207

Ejemplares similares